Agranulocytosis during therapy with a brompheniramine-medication.
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D001977:Brompheniramine / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology*; D006801:Humans; D008297:Male; D011725:Pyridines / Q000009:adverse effects*
D011725:Pyridines; D001977:Brompheniramine